Cite Filings / RXRX / 0001628280-25-058427
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

RECURSION PHARMACEUTICALS, INC. · Filed 2025-12-22 · Acc 0001628280-25-058427

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-12-29 144 Sale of Securities
  • 2025-12-29 4 Chief R&D Commercial Officer sold 124,403 shares at $4.41 ($548,592)
  • 2025-12-23 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-12-22 144 Sale of Securities
  • 2025-12-19 144 Sale of Securities
  • 2025-12-19 4 Chief Executive Officer sold 40,000 shares at $4.50 ($180,000)
  • 2025-12-17 4 Chief Financial Officer gave up 7,057 shares (to pay taxes)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…